siRNA treatment reduces triglycerides in patients along with rare condition

.ANALYSIS FEATURE.19 September 2024.

Plozasiran reduced triglyceride degrees through 80% as well as reduced the threat of pancreatitis in patients along with chronic chylomicronemia, with or even without a genetic medical diagnosis.